|Bid||21.40 x 800|
|Ask||21.41 x 1400|
|Day's Range||21.26 - 22.04|
|52 Week Range||5.12 - 25.10|
|Beta (3Y Monthly)||4.28|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
DENVER, March 19, 2019 /CNW/ -- The growth of the hemp sector is having a beneficial effect for both hemp companies and hydroponic suppliers. Sugarmade Inc. (OTC:SGMD - News) (SGMD Profile) via its pending acquisitions is poised to accelerate its growth rate as a result of this hemp cultivation boom, along with other leading companies. Tilray Inc. (NASDAQ:TLRY - News) has been expanding through the acquisition of other companies and a move into Europe, with a successful harvest in Portugal.
HENDERSON, NV / ACCESSWIRE / March 19, 2019 / From a dirty little secret to one of the fastest growing industries in the world, cannabis has come a long way. As more states are legalizing medical marijuana ...
The statistics show that cannabis consumption has increased among the older generations since the previous survey in 2013 as almost a quarter of those over 65 were prescribed cannabis as a treatment from their doctors in 2016. While recreational cannabis laws are still regulated in most U.S. states and even internationally, medical cannabis regulations are much more lenient because of the plant's therapeutic effects. Now, consumers are using cannabis to treat medical conditions such as cancer, chronic pain, and arthritis.
PALM BEACH, Florida, March 13, 2019 /CNW/ -- The passage of the U.S. Farm bill, which restored industrial hemp to nationwide legal production for the first time since World War II, has been generating a financial windfall for North American cannabis companies. A recent post from industry watchers on the net said: "More broadly, the passage of the Farm Bill represents a sweeping change in the balance of power in global hemp markets. The United States has historically been an importer of hemp products from Canada, Europe, and China.
In regards to the cannabis industry's recent bull run, the positive trends can be attributed to two key factors: legislative efforts and a general shift in public opinion. Recently, lawmakers have advocated for legislation in support of cannabis legislation, and this has given cannabis companies more societal credibility. Transcanna Holdings Inc (TCAN.CN), Aphria Inc (NYSE:APHA), Harvest Health & Recreation Inc (HARV.CN), and Cronos Group Inc (CRON) are four cannabis companies worth looking into.
LOS ANGELES, March 12, 2019 /CNW/ -- It appears that there is strong consensus amongst major populations groups who will ultimately determine the viability of legal marijuana in the US. The news is further support for the development by a broad group of cannabis and CBD companies who are preparing for adoption with efforts to fill the new demand for marijuana, hemp and CBD products including Tilray, Inc. (NASDAQ:TLRY - News), Cronos Group (NASDAQ:CRON - News) (TSX:CRON.TO - News) and AmeriCann, Inc. (OTC:ACAN - News). As this trend takes hold, the CBD products sector is expected to grow at an equal pace.
Altria (MO) closes investment deal in Cronos Group. The move is in sync with the company's efforts to expand in the smokeless category.
HENDERSON, NV / ACCESSWIRE / March 11, 2019 / From the beginning of the year (YTD) to March 9, 2019, the first tradable cannabis ETF, the Horizons Marijuana Life Sciences Index ETF, was up over 50%. Unfortunately, ...
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) today announced that the C$2.4 billion equity investment in the Company by Altria Group, Inc. (MO) (“Altria”) has closed. As previously announced, Altria’s investment represents an approximate 45% ownership interest in Cronos Group.
Altria’s investment represents an approximate 45% economic and voting interest in Cronos Group with a warrant to acquire additional ownership at a price of CAD $19.00 per share, exercisable over the next four years. If exercised in full today, the warrant would increase Altria’s ownership in Cronos Group to approximately 55%. Under the terms of the transaction, Altria nominated four directors who were recently elected to serve on Cronos Group’s seven member board: Kevin C. Crosthwaite, Jr., Murray R. Garnick, Bruce A. Gates and Bronwen Evans.
PALM BEACH, Florida, March 7, 2019 /CNW/ -- In an article titled: "The Economics of Extraction" the Cannabis Business Times (CBT) predicted that consumers will demand more and more retail choices: "CBT reported that vape cartridge sales in California reached $100 million for the combined months of November and December 2017. The stated total of all concentrate revenue in California for that same period was $140.9 million Based on those figures, it's clear that vape cartridges dominate sales. The simple answer: user convenience." The article continued: "With this data, some companies will successfully focus strictly on cartridge sales, but the cartridge industry is destined to become competitive and saturated.
CRON, ACB, WEED, and APHA Bleed after a Run-Up YesterdayCannabis sector ETFs The cannabis sector ETFs were trading in the red in the first half of the day, with the Horizons Marijuana Life Sciences ETF (HMMJ) falling 1.7% and the ETFMG Alternative
Aurora Cannabis (TSX: ACB) (NYSE: ACB) has announced that it has acquired privately-held Whistler Medical Marijuana in an all-share transaction. The company bought all issued and outstanding shares of Whistler under the terms of an agreement among Whistler, Aurora, and a wholly-owned subsidiary of Aurora. In a separate statement, Cronos Group (NASDAQ: CRON) (TSX: CRON) said […]The post Aurora Acquires Premium Cannabis Products Maker appeared first on Market Exclusive.
NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.
Why Aphria Could Squeeze Out Short Sellers(Continued from Prior Part)Short sellers’ claims Aphria (APHA) received severe criticism from short sellers late last year over its acquisition in Latin America. Short sellers even rushed to call Aphria
CORAL GABLES, FL / ACCESSWIRE / March 5, 2019 / The marijuana stock market has become the focal point of conversation over the course of the past few years, resulting in a bullish run for companies in the cannabis industry. Over that time period, countless new companies in the industry have gained notoriety for their innovative approaches to creating cannabis products for consumers. With the majority of U.S. states having some form of legal cannabis, either recreational or medicinal, the marijuana industry is whirring with excitement.
Cronos Group Got a ‘Market Perform’ Rating from Cowen“Market perform” for Cronos GroupOn March 5, Cowen initiated coverage on Cronos Group (CRON) with a “market perform” rating. Cowen also initiated coverage on Aurora Cannabis (ACB) with
Aurora Cannabis Got an ‘Outperform’ Rating from CowenCowen initiates coverage on Aurora Cannabis On March 5, Cowen initiated coverage on Aurora Cannabis (ACB) with an “outperform” rating. Cowen joins an increasing number of investment firms
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”), confirmed today that it has sold all of its common shares in the capital of Whistler Medical Marijuana Corporation ("Whistler"), representing approximately 19 percent of Whistler’s issued and outstanding common shares, to Aurora Cannabis Inc. (“Aurora”) for a total purchase price of approximately C$175 million, payable by the issuance of common shares in the capital of Aurora (“Aurora Common Shares”), and subject to certain working capital adjustments and holdbacks (the “Transaction”).